The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 29, 2017

Filed:

Jun. 29, 2016
Applicants:

Ic-medtech Corporation, Las Vegas, NV (US);

Mayo Foundation for Medical Education and Research, Rochester, MN (US);

Inventors:

Thomas M. Miller, Las Vegas, NV (US);

Tetyana V. Masyuk, Rochester, MN (US);

Nicholas F. Larusso, Rochester, MN (US);

Assignee:

IC-MedTech Corporation, Las Vegas, NV (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/375 (2006.01); A61K 31/122 (2006.01); A61K 9/48 (2006.01); A61K 31/185 (2006.01); A61K 9/20 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/375 (2013.01); A61K 9/0019 (2013.01); A61K 9/2054 (2013.01); A61K 9/48 (2013.01); A61K 31/122 (2013.01); A61K 31/185 (2013.01); A61K 9/0014 (2013.01);
Abstract

Provided herein is a pharmaceutical composition comprising vitamin C and chromium-free vitamin K, and optionally one or more pharmaceutically acceptable excipient(s). Also provided herein is a chromium-free pharmaceutical composition comprising vitamin C and vitamin K, and optionally one or more pharmaceutically acceptable excipient(s). Further provided herein is a method of treating, preventing, or managing an NFκB-mediated condition, disorder, or disease, comprising administering to the subject a therapeutically effective amount of vitamin C and chromium-free vitamin K. Provided herein are methods for treating, preventing, or ameliorating one or more symptoms of a polycystic disease in a subject, comprising administering to the subject a therapeutically effective amount of vitamins C and K.


Find Patent Forward Citations

Loading…